Abstract Details
David Pellerin, MD
PRESENTER |
Dr. Pellerin has nothing to disclose. |
Matt Danzi (University of Miami) | Matt Danzi has nothing to disclose. |
Carlo Wilke | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
Marie-Josee Dicaire | Marie-Josee Dicaire has nothing to disclose. |
No disclosure on file | |
Catherine Ashton, MBBS (Catherine Ashton) | Dr. Ashton has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
Sara Nagy, MD (Deparment of Neurology, University Hospital Basel) | Dr. Nagy has nothing to disclose. |
No disclosure on file | |
Kym Boycott | No disclosure on file |
Antoine Duquette, MD (CHUM) | Dr. Duquette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. The institution of Dr. Duquette has received research support from Actelion. The institution of Dr. Duquette has received research support from Ataxia Canada/FARA. |
Henry Houlden | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Ludger Schols, MD (Eberhard-Karls-University) | Dr. Schols has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VICO Therapeutics. Dr. Schols has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schols has received research support from Vigil. |
Roberta La Piana | Roberta La Piana has received research support from Canadian Institute Health Research. Roberta La Piana has received research support from Ataxia Canada. Roberta La Piana has received research support from Spastic Paraplegia Foundation. Roberta La Piana has received research support from Fonds de Recherche en Santé du Quebec. Roberta La Piana has received research support from Roche Canada. |
Matthis Synofzik (Hertie-Institute for Clinical Brain Research) | Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD. |
Stephan Zuchner, MD, FAAN (University of Miami School of Medicine) | Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care. |
Bernard Brais, MD | Dr. Brais has nothing to disclose. |